Registration No. 333-


                        SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                     FORM S-8
                              REGISTRATION STATEMENT
                                     UNDER
                            THE SECURITIES ACT OF 1933


                            THE PERKIN-ELMER CORPORATION
               (Exact Name of Registrant as Specified in Its Charter)

                    New York                                 06-0490270
        (State or Other Jurisdiction of                  (I.R.S. Employer
        Incorporation or Organization)                   Identification Number)


                                   761 MAIN AVENUE
                           NORWALK, CONNECTICUT  06859-0001
                (Address of Principal Executive Offices, including Zip Code)


                           MOLECULAR INFORMATICS, INC.
                           1997 EQUITY OWNERSHIP PLAN
                           (Full Title of the Plan)


                              WILLIAM B. SAWCH
              Senior Vice President, General Counsel and Secretary
                        THE PERKIN-ELMER CORPORATION
                            761 Main Avenue
                      Norwalk, Connecticut 06859-0001
                             (203) 762-1000
            (Name, Address, and Telephone Number of Agent for Service)




                         CALCULATION OF REGISTRATION FEE

                                     Proposed    Proposed
                                     Maximum     Maximum
                                     Offering    Aggregate
Title of Securities   Amount to be   Price Per   Offering    Amount of
to be Registered      Registered     Share (1)   Price (1)   Registration Fee
Common Stock, $1.00
Par Value (2)             64,689     $63.7188    $4,121,905     $1,216


1. Pursuant to Rule 457(h)(1) and Rule 457(c), the proposed maximum
offering price per share and the registration fee are based upon the
reported average of the high and low prices for the common stock of the
Registrant (the "Common Stock") on the New York Stock Exchange on
December 17, 1997.  The maximum offering price per share is estimated
solely for purposes of calculating the registration fee.
2. This Registration Statement also pertains to rights to purchase
Participating Preferred Stock of the Registrant (the "Rights").  Until
the occurrence of certain prescribed events, the Rights are not
exercisable, are evidenced by the certificates for Common Stock, and
will be transferred along with and only with such securities.
Thereafter, separate Rights certificates will be issued representing one
Right for each share of Common Stock held, subject to adjustment
pursuant to anti-dilution provisions.




<PAGE>

                                 PART I

        INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS


Item 1. Plan Information.

 Not required to be filed with this Registration Statement.


Item 2. Registrant Information and Employee Plan Annual
Information.

 Not required to be filed with this Registration Statement.



                                 PART II

       INFORMATION REQUIRED IN THE REGISTRATION STATEMENT


Item 3. Incorporation of Documents by Reference.

 The following documents filed by The Perkin-Elmer
Corporation (the "Company") with the Securities and Exchange
Commission (the "Commission") are incorporated in this
Registration Statement by reference:

   (1) The Company's Annual Report on Form 10-K for the
fiscal year ended June 30, 1997.

   (2) The Company's Quarterly Report on Form 10-Q for
the quarterly period ended September 30, 1997.

   (3) The Company's Current Report on Form 8-K dated
August 23, 1997 and filed on August 26, 1997.

   (4) The descriptions of the Company's Common Stock and
the rights to purchase the Company's Participating Preferred
Stock, par value $1.00 per share, contained in the Company's
Registration Statements filed pursuant to Section 12 of the
Securities Exchange Act of 1934, as amended (the "1934 Act"),
including any amendment or report filed for the purpose of
updating such descriptions.

 All documents filed by the Company with the Commission
pursuant to Sections 13(a), 13(c), 14 or 15(d) of the
1934 Act, prior to the filing of a post-effective
amendment which indicates that all securities offered
have been sold or which deregisters all securities then


                           -1-

<PAGE>

remaining unsold shall be deemed to be incorporated by
reference in this Registration Statement and to be a part
hereof from their respective dates of filing (such
documents, and the documents enumerated above, being
hereinafter referred to as "Incorporated Documents");
provided, however, that the documents enumerated above or
subsequently filed by the Company pursuant to Sections
13(a), 13(c), 14 and 15(d) of the 1934 Act in each year
during which the offering made by this Registration
Statement is in effect prior to the filing with the
Commission of the Company's Annual Report on Form 10-K
covering such year shall not be Incorporated Documents or be
incorporated by reference in this Registration Statement or
be a part hereof from and after the filing of such Annual
Report on Form 10-K.

 Any statement contained in an Incorporated Document shall be
deemed to be modified or superseded for purposes of this
Registration Statement to the extent that a statement contained
herein or in any other subsequently filed Incorporated Document
modifies or supersedes such statement.  Any such statement so
modified or superseded shall not be deemed, except as so modified
or superseded, to constitute a part of this Registration
Statement.


Item 4. Description of Securities.

 Not applicable.


Item 5. Interests of Named Experts and Counsel.

 Legal matters in connection with the shares of Common Stock
subject to issuance pursuant to the Molecular Informatics, Inc.
1997 Equity Ownership Plan have been passed upon by William B.
Sawch, Esq., Senior Vice President, General Counsel and Secretary
of the Company.  Mr. Sawch owns Common Stock of the Company and
options to purchase Common Stock of the Company with an aggregate
value in excess of $50,000.


Item 6. Indemnification of Directors and Officers.

The New York Business Corporation Law (the "NYBCL")
authorizes a New York corporation to indemnify any person
who is, or is threatened to be made, a party in any civil or
criminal proceeding (other than an action by or in the right
of the corporation) by reason of the fact that he or she is
or was a director, officer, employee or agent of the
corporation, or is or was serving at the request of the
corporation as a director, officer, employee or agent of
another entity, against judgments, fines, amounts paid in
settlement and reasonable expenses (including attorneys'
fees) actually and necessarily incurred by such person as a
result of such action or proceeding or any appeal therein.
With respect to actions by or in the right of the
corporation, the NYBCL authorizes indemnification of such
person against reasonable expenses including attorneys' fees
and amounts paid in settlement.  To be entitled to
indemnification, a person must have acted in good faith, for
a purpose which he or she reasonably believed to be in, or
in the case of service for another organization, not opposed
to, the best interests of the corporation and,


                           -2-

<PAGE>


with respect to any criminal action or proceeding, in
addition, had no reasonable cause to believe his or her
conduct was unlawful.  Court approval is required as a
prerequisite to indemnification of expenses in respect of
any claim as to which a person has been adjudged liable to
the corporation.

 The NYBCL requires indemnification against expenses actually
and reasonably incurred by any director, officer, employee or
agent in connection with a proceeding against such person for
action in such capacity to the extent that the person has been
successful on the merits or otherwise.  Advancement of expenses
(i.e., payment prior to a determination on the merits) is
permitted, but not required, by the NYBCL, which further requires
that any director or officer must undertake to repay such
expenses if it is ultimately determined that he or she is not
entitled to indemnification.  The disinterested members of the
board of directors (or independent legal counsel or the
shareholders) must determine, in each instance where
indemnification is not required by the NYBCL, that such director,
officer, employee or agent is entitled to indemnification.  The
NYBCL provides that the indemnification provided by statute is
not exclusive.

 The Company's By-Laws provide that, except to the extent
expressly prohibited by the NYBCL, the Company shall indemnify
each person made or threatened to be made a party to, or called
as a witness or asked to submit information in, any action or
proceeding by reason of the fact that such person or such
person's testator or intestate is or was a director or officer of
the Company, or serves or served at the request of the Company
any other corporation, partnership, joint venture, trust,
employee benefit plan or other enterprise in any capacity,
against judgments, fines, penalties, amounts paid in settlement
and reasonable expenses, including attorneys' fees, incurred in
connection with such action or proceeding, or any appeal therein,
provided that no such indemnification shall be made if a judgment
or other final adjudication adverse to such person establishes
that his or her acts were committed in bad faith or were the
result of active and deliberate dishonesty and were material to
the cause of the action so adjudicated, or that he or she
personally gained in fact a financial profit or other advantage
to which he or she was not legally entitled, and provided further
that no such indemnification shall be required with respect to
any settlement or other nonadjudicated disposition of any
threatened or pending action or proceeding unless the Company has
given its prior consent to such settlement or other disposition.
Reference to an action or proceeding in these By-Laws includes,
without limitation, any pending or threatened action, proceeding,
hearing or investigation, whether civil or criminal, whether
judicial, administrative or legislative in nature and whether or
not in the nature of a direct or a shareholders' derivative
action brought by or on behalf of the Company or any other
corporation or enterprise which the director or officer of the
corporation serves at the Company's request.

 The Company's By-Laws further provide that the Company shall advance
or promptly reimburse upon request any person entitled to
indemnification hereunder for all expenses, including attorneys' fees,
reasonably incurred in defending any action or proceeding in advance
of the final disposition thereof upon receipt of an undertaking by or
on behalf of such person to repay such amount if such person is
ultimately found not to be entitled to indemnification or, where
indemnification is granted, to the extent the expenses so advanced or
reimbursed exceed the amount to which such person is entitled,
provided, however, that such person shall cooperate


                           -3-

<PAGE>



in good faith with any request by the Company that
common counsel be utilized by the parties to an action or
proceeding who are similarly situated unless to do so would
be inappropriate due to actual or potential differing
interests between or among such parties.  The Company shall
also promptly pay or reimburse such person for all expenses,
including fees and expenses of counsel, reasonably incurred
by such person in successfully enforcing his or her rights
pursuant to the By-Law provisions described above.


Item 7. Exemption from Registration Claimed.

  Not applicable
 .

Item 8. Exhibits.

Exhibit 4(1)      -  Three Year Credit Agreement
                     dated June 1, 1994 among Morgan Guaranty
                     Trust Company, certain banks named in
                     such Agreement, and the Company, as
                     amended July 20, 1995 (Incorporated by
                     reference to Exhibit 4(1) to the
                     Company's Annual Report on Form 10-K for
                     the fiscal year ended June 30, 1995
                     (Commission file number 1-4389)).

Exhibit 4(2)      -  Amendment dated as of March
                     31, 1996 to the Three Year Credit
                     Agreement dated as of June 1, 1994 among
                     Morgan Guaranty Trust Company, certain
                     banks named in such agreement, and the
                     Company, as amended July 20, 1995
                     (Incorporated by reference to Exhibit
                     4(2) to the Company's Annual Report on
                     Form 10-K for the fiscal year ended June
                     30, 1997 (Commission file number 1-
                     4389)).

Exhibit 4(3)      -  Shareholder Protection Rights
                     Agreement dated April 30, 1989 between
                     the Company and The First National Bank
                     of Boston (Incorporated by reference to
                     Exhibit 4 to the Company's Current
                     Report on Form 8-K dated April 20, 1989
                     (Commission file number 1-4389)).

Exhibit 5         -  Opinion of William B. Sawch,
                     Esq. (including Consent).

Exhibit 23(1)     -  Consent of Price Waterhouse LLP.


Exhibit 23(2)     - Consent of William B. Sawch, Esq.
                    (included in Exhibit 5).

Exhibit 24        - Power of Attorney (contained
                    on the signature pages hereof).


                           -4-

<PAGE>

Exhibit 99       - Molecular Informatics, Inc.
                   1997 Equity Ownership Plan.



Item 9. Undertakings.

        (a)  The Company hereby undertakes:

        (1)  To file, during any period in which offers or sales are
being made, a post-effective amendment to this registration statement:


                (i)  To include any prospectus required by Section
             10(a)(3) of the Securities Act of 1933 (the "1933 Act");

               (ii)  To reflect in the prospectus any facts or events
             arising after the effective date of the registration
             statement (or the most recent post-effective amendment
             thereof) which, individually or in the aggregate, represent
             a fundamental change in the information set forth in the
             registration statement; and

               (iii)  To include any material information with respect
             to the plan of distribution not previously disclosed in the
             registration statement or any material change to such
             information in the registration statement;

provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do
not apply if the information required to be included in a post-
effective amendment by those paragraphs is contained in periodic
reports filed with or furnished to the Commission by the Company
pursuant to Section 13 or Section 15(d) of the 1934 Act that are
incorporated by reference in the registration statement;

        (2)  That, for the purpose of determining any liability
under the 1933 Act, each such post-effective amendment shall be
deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering
thereof; and

        (3)  To remove from registration by means of a post-
effective amendment any of the securities being registered which
remain unsold at the termination of the offering.

        (b)  The Company hereby undertakes that, for purposes of
determining any liability under the 1933 Act, each filing of the
Company's annual report pursuant to Section 13(a) or Section
15(d) of the 1934 Act (and, where applicable, each filing of an
employee benefit plan's annual report pursuant to Section 15(d)
of the 1934 Act) that is incorporated by reference in the
registration statement shall be deemed to be a new registration
statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.



                           -5-

<PAGE>

        (c)  Insofar as indemnification for liabilities arising
under the 1933 Act may be permitted to directors, officers and
controlling persons of the Company pursuant to the foregoing
provisions, or otherwise, the Company has been advised that in
the opinion of the Commission such indemnification is against
public policy as expressed in the 1933 Act and is, therefore,
unenforceable.  In the event that a claim for indemnification
against such liabilities (other than the payment by the Company
of expenses incurred or paid by a director, officer or
controlling person of the Company in the successful defense of
any action, suit or proceeding) is asserted by such director,
officer or controlling person in connection with the securities
being registered, the Company will, unless in the opinion of its
counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question
whether such indemnification by it is against public policy as
expressed in the 1933 Act and will be governed by the final
adjudication of such issue.


                           -6-

<PAGE>


                         SIGNATURES


 Pursuant to the requirements of the Securities Act of 1933,
the Company certifies that it has reasonable grounds to believe
that it meets all of the requirements for filing on Form S-8 and
has duly caused this Registration Statement to be signed on its
behalf by the undersigned, thereunto duly authorized, in the City
of Norwalk, State of Connecticut, on November 30, 1997.

                                THE PERKIN-ELMER CORPORATION


                               By:  /s/ William B. Sawch
                                    William B. Sawch
                                    Senior Vice President, General
                                    Counsel and Secretary


                       POWER OF ATTORNEY


 KNOW ALL MEN BY THESE PRESENTS, that each person whose
signature appears below hereby constitutes and appoints Dennis L.
Winger and William B. Sawch, and each of them, his true and
lawful attorney-in-fact and agent, with full power of
substitution and resubstitution, for him and in his name, place
and stead, in any and all capacities, to sign any and all
amendments (including, without limitation, post-effective
amendments) to this Registration Statement, and to file the same,
with all exhibits thereto, and other documents in connection
therewith, with the Securities and Exchange Commission, granting
unto said attorneys-in-fact and agents, and each of them, full
power and authority to do and perform each and every act and
thing requisite and necessary to be done in and about the
premises as fully to all intents and purposes as he might or
could do in person, hereby ratifying and confirming all that said
attorneys-in-fact and agents of any of them, or their or his
substitute or substitutes, may lawfully do or cause to be done by
virtue hereof.

 Pursuant to the requirements of the Securities Act of 1933,
this Registration Statement has been signed by the following
persons in the capacities and on the dates indicated.

<TABLE>

<S>                                <C>                            <C>
 /s/ Tony L. White                  Chairman of the Board,         November 30, 1997
     Tony L. White                  President and Chief
                                    Executive Officer
                                    (Principal Executive Officer)

</TABLE>
                           -7-

<PAGE>


<TABLE>

<S>                                <C>                            <C>
/s/ Dennis L. Winger                Senior Vice President,         November 30, 1997
    Dennis L. Winger                Chief Financial Officer
                                    and Treasurer (Principal
                                    Financial Officer)

 /s/ Ugo D. DeBlasi                 Corporate Controller           November 30, 1997
     Ugo D. DeBlasi                 (Principal Accounting
                                    Officer)


/s/ Joseph F. Abely, Jr.            Director                       November 30, 1997
    Joseph F. Abely, Jr.


/s/ Richard H. Ayers                Director                       November 30, 1997
    Richard H. Ayers


                                    Director                       November   , 1997
Jean-Luc Belingard


/s/ Robert H. Hayes                 Director                       November 30, 1997
    Robert H. Hayes


/s/ Georges C. St. Laurent, Jr.     Director                       November 30, 1997
    Georges C. St. Laurent, Jr.


/s/ Carolyn W. Slayman              Director                       November 30, 1997
Carolyn W. Slayman


                                    Director                       November    , 1997
Orin R. Smith

</TABLE>

                           -8-

<PAGE>




                            EXHIBIT INDEX


                Exhibit No.                     Exhibit


                  5              Opinion of William B. Sawch, Esq.

                 23(1)           Consent of Price Waterhouse

                 99              Molecular Informatics, Inc. 1997 Equity
                                 Ownership Plan
[{"type": "S-8", "sequence": "1", "description": "1997 EQUITY OWNERSHIP PLAN", "secsgml_size_bytes": 21734}]
{"company-data": {"conformed-name": "PERKIN ELMER CORP", "cik": "0000077551", "assigned-sic": "3826", "irs-number": "060490270", "state-of-incorporation": "NY", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-42683", "film-number": "97741046"}, "business-address": {"street1": "761 MAIN AVE", "city": "NORWALK", "state": "CT", "zip": "06859-0001", "phone": "2037621000"}, "mail-address": {"street1": "761 MAIN AVENUE", "city": "NORWALK", "state": "CT", "zip": "06859-0001"}}
Registration No. 333-

                        SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                     FORM S-8
                              REGISTRATION STATEMENT
                                     UNDER
                            THE SECURITIES ACT OF 1933

                            THE PERKIN-ELMER CORPORATION
               (Exact Name of Registrant as Specified in Its Charter)

                    New York                                 06-0490270
        (State or Other Jurisdiction of                  (I.R.S. Employer
        Incorporation or Organization)                   Identification Number)

                                   761 MAIN AVENUE
                           NORWALK, CONNECTICUT  06859-0001
                (Address of Principal Executive Offices, including Zip Code)

                           MOLECULAR INFORMATICS, INC.
                           1997 EQUITY OWNERSHIP PLAN
                           (Full Title of the Plan)

                              WILLIAM B. SAWCH
              Senior Vice President, General Counsel and Secretary
                        THE PERKIN-ELMER CORPORATION
                            761 Main Avenue
                      Norwalk, Connecticut 06859-0001
                             (203) 762-1000
            (Name, Address, and Telephone Number of Agent for Service)

                         CALCULATION OF REGISTRATION FEE

                                     Proposed    Proposed
                                     Maximum     Maximum
                                     Offering    Aggregate
Title of Securities   Amount to be   Price Per   Offering    Amount of
to be Registered      Registered     Share (1)   Price (1)   Registration Fee
Common Stock, $1.00
Par Value (2)             64,689     $63.7188    $4,121,905     $1,216

1. Pursuant to Rule 457(h)(1) and Rule 457(c), the proposed maximum
offering price per share and the registration fee are based upon the
reported average of the high and low prices for the common stock of the
Registrant (the "Common Stock") on the New York Stock Exchange on
December 17, 1997.  The maximum offering price per share is estimated
solely for purposes of calculating the registration fee.
2. This Registration Statement also pertains to rights to purchase
Participating Preferred Stock of the Registrant (the "Rights").  Until
the occurrence of certain prescribed events, the Rights are not
exercisable, are evidenced by the certificates for Common Stock, and
will be transferred along with and only with such securities.
Thereafter, separate Rights certificates will be issued representing one
Right for each share of Common Stock held, subject to adjustment
pursuant to anti-dilution provisions.
PART I

        INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

Item 1. Plan Information.

 Not required to be filed with this Registration Statement.

Item 2. Registrant Information and Employee Plan Annual
Information.

 Not required to be filed with this Registration Statement.

                                 PART II

       INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3. Incorporation of Documents by Reference.

 The following documents filed by The Perkin-Elmer
Corporation (the "Company") with the Securities and Exchange
Commission (the "Commission") are incorporated in this
Registration Statement by reference:

   (1) The Company's Annual Report on Form 10-K for the
fiscal year ended June 30, 1997.

   (2) The Company's Quarterly Report on Form 10-Q for
the quarterly period ended September 30, 1997.

   (3) The Company's Current Report on Form 8-K dated
August 23, 1997 and filed on August 26, 1997.

   (4) The descriptions of the Company's Common Stock and
the rights to purchase the Company's Participating Preferred
Stock, par value $1.00 per share, contained in the Company's
Registration Statements filed pursuant to Section 12 of the
Securities Exchange Act of 1934, as amended (the "1934 Act"),
including any amendment or report filed for the purpose of
updating such descriptions.

 All documents filed by the Company with the Commission
pursuant to Sections 13(a), 13(c), 14 or 15(d) of the
1934 Act, prior to the filing of a post-effective
amendment which indicates that all securities offered
have been sold or which deregisters all securities then

                           -1-
remaining unsold shall be deemed to be incorporated by
reference in this Registration Statement and to be a part
hereof from their respective dates of filing (such
documents, and the documents enumerated above, being
hereinafter referred to as "Incorporated Documents");
provided, however, that the documents enumerated above or
subsequently filed by the Company pursuant to Sections
13(a), 13(c), 14 and 15(d) of the 1934 Act in each year
during which the offering made by this Registration
Statement is in effect prior to the filing with the
Commission of the Company's Annual Report on Form 10-K
covering such year shall not be Incorporated Documents or be
incorporated by reference in this Registration Statement or
be a part hereof from and after the filing of such Annual
Report on Form 10-K.

 Any statement contained in an Incorporated Document shall be
deemed to be modified or superseded for purposes of this
Registration Statement to the extent that a statement contained
herein or in any other subsequently filed Incorporated Document
modifies or supersedes such statement.  Any such statement so
modified or superseded shall not be deemed, except as so modified
or superseded, to constitute a part of this Registration
Statement.

Item 4. Description of Securities.

 Not applicable.

Item 5. Interests of Named Experts and Counsel.

 Legal matters in connection with the shares of Common Stock
subject to issuance pursuant to the Molecular Informatics, Inc.
1997 Equity Ownership Plan have been passed upon by William B.
Sawch, Esq., Senior Vice President, General Counsel and Secretary
of the Company.  Mr. Sawch owns Common Stock of the Company and
options to purchase Common Stock of the Company with an aggregate
value in excess of $50,000.

Item 6. Indemnification of Directors and Officers.

The New York Business Corporation Law (the "NYBCL")
authorizes a New York corporation to indemnify any person
who is, or is threatened to be made, a party in any civil or
criminal proceeding (other than an action by or in the right
of the corporation) by reason of the fact that he or she is
or was a director, officer, employee or agent of the
corporation, or is or was serving at the request of the
corporation as a director, officer, employee or agent of
another entity, against judgments, fines, amounts paid in
settlement and reasonable expenses (including attorneys'
fees) actually and necessarily incurred by such person as a
result of such action or proceeding or any appeal therein.
With respect to actions by or in the right of the
corporation, the NYBCL authorizes indemnification of such
person against reasonable expenses including attorneys' fees
and amounts paid in settlement.  To be entitled to
indemnification, a person must have acted in good faith, for
a purpose which he or she reasonably believed to be in, or
in the case of service for another organization, not opposed
to, the best interests of the corporation and,

                           -2-
with respect to any criminal action or proceeding, in
addition, had no reasonable cause to believe his or her
conduct was unlawful.  Court approval is required as a
prerequisite to indemnification of expenses in respect of
any claim as to which a person has been adjudged liable to
the corporation.

 The NYBCL requires indemnification against expenses actually
and reasonably incurred by any director, officer, employee or
agent in connection with a proceeding against such person for
action in such capacity to the extent that the person has been
successful on the merits or otherwise.  Advancement of expenses
(i.e., payment prior to a determination on the merits) is
permitted, but not required, by the NYBCL, which further requires
that any director or officer must undertake to repay such
expenses if it is ultimately determined that he or she is not
entitled to indemnification.  The disinterested members of the
board of directors (or independent legal counsel or the
shareholders) must determine, in each instance where
indemnification is not required by the NYBCL, that such director,
officer, employee or agent is entitled to indemnification.  The
NYBCL provides that the indemnification provided by statute is
not exclusive.

 The Company's By-Laws provide that, except to the extent
expressly prohibited by the NYBCL, the Company shall indemnify
each person made or threatened to be made a party to, or called
as a witness or asked to submit information in, any action or
proceeding by reason of the fact that such person or such
person's testator or intestate is or was a director or officer of
the Company, or serves or served at the request of the Company
any other corporation, partnership, joint venture, trust,
employee benefit plan or other enterprise in any capacity,
against judgments, fines, penalties, amounts paid in settlement
and reasonable expenses, including attorneys' fees, incurred in
connection with such action or proceeding, or any appeal therein,
provided that no such indemnification shall be made if a judgment
or other final adjudication adverse to such person establishes
that his or her acts were committed in bad faith or were the
result of active and deliberate dishonesty and were material to
the cause of the action so adjudicated, or that he or she
personally gained in fact a financial profit or other advantage
to which he or she was not legally entitled, and provided further
that no such indemnification shall be required with respect to
any settlement or other nonadjudicated disposition of any
threatened or pending action or proceeding unless the Company has
given its prior consent to such settlement or other disposition.
Reference to an action or proceeding in these By-Laws includes,
without limitation, any pending or threatened action, proceeding,
hearing or investigation, whether civil or criminal, whether
judicial, administrative or legislative in nature and whether or
not in the nature of a direct or a shareholders' derivative
action brought by or on behalf of the Company or any other
corporation or enterprise which the director or officer of the
corporation serves at the Company's request.

 The Company's By-Laws further provide that the Company shall advance
or promptly reimburse upon request any person entitled to
indemnification hereunder for all expenses, including attorneys' fees,
reasonably incurred in defending any action or proceeding in advance
of the final disposition thereof upon receipt of an undertaking by or
on behalf of such person to repay such amount if such person is
ultimately found not to be entitled to indemnification or, where
indemnification is granted, to the extent the expenses so advanced or
reimbursed exceed the amount to which such person is entitled,
provided, however, that such person shall cooperate

                           -3-
in good faith with any request by the Company that
common counsel be utilized by the parties to an action or
proceeding who are similarly situated unless to do so would
be inappropriate due to actual or potential differing
interests between or among such parties.  The Company shall
also promptly pay or reimburse such person for all expenses,
including fees and expenses of counsel, reasonably incurred
by such person in successfully enforcing his or her rights
pursuant to the By-Law provisions described above.

Item 7. Exemption from Registration Claimed.

  Not applicable
 .

Item 8. Exhibits.

Exhibit 4(1)      -  Three Year Credit Agreement
                     dated June 1, 1994 among Morgan Guaranty
                     Trust Company, certain banks named in
                     such Agreement, and the Company, as
                     amended July 20, 1995 (Incorporated by
                     reference to Exhibit 4(1) to the
                     Company's Annual Report on Form 10-K for
                     the fiscal year ended June 30, 1995
                     (Commission file number 1-4389)).

Exhibit 4(2)      -  Amendment dated as of March
                     31, 1996 to the Three Year Credit
                     Agreement dated as of June 1, 1994 among
                     Morgan Guaranty Trust Company, certain
                     banks named in such agreement, and the
                     Company, as amended July 20, 1995
                     (Incorporated by reference to Exhibit
                     4(2) to the Company's Annual Report on
                     Form 10-K for the fiscal year ended June
                     30, 1997 (Commission file number 1-
                     4389)).

Exhibit 4(3)      -  Shareholder Protection Rights
                     Agreement dated April 30, 1989 between
                     the Company and The First National Bank
                     of Boston (Incorporated by reference to
                     Exhibit 4 to the Company's Current
                     Report on Form 8-K dated April 20, 1989
                     (Commission file number 1-4389)).

Exhibit 5         -  Opinion of William B. Sawch,
                     Esq. (including Consent).

Exhibit 23(1)     -  Consent of Price Waterhouse LLP.

Exhibit 23(2)     - Consent of William B. Sawch, Esq.
                    (included in Exhibit 5).

Exhibit 24        - Power of Attorney (contained
                    on the signature pages hereof).

                           -4-
Exhibit 99       - Molecular Informatics, Inc.
                   1997 Equity Ownership Plan.

Item 9. Undertakings.

        (a)  The Company hereby undertakes:

        (1)  To file, during any period in which offers or sales are
being made, a post-effective amendment to this registration statement:

                (i)  To include any prospectus required by Section
             10(a)(3) of the Securities Act of 1933 (the "1933 Act");

               (ii)  To reflect in the prospectus any facts or events
             arising after the effective date of the registration
             statement (or the most recent post-effective amendment
             thereof) which, individually or in the aggregate, represent
             a fundamental change in the information set forth in the
             registration statement; and

               (iii)  To include any material information with respect
             to the plan of distribution not previously disclosed in the
             registration statement or any material change to such
             information in the registration statement;

provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do
not apply if the information required to be included in a post-
effective amendment by those paragraphs is contained in periodic
reports filed with or furnished to the Commission by the Company
pursuant to Section 13 or Section 15(d) of the 1934 Act that are
incorporated by reference in the registration statement;

        (2)  That, for the purpose of determining any liability
under the 1933 Act, each such post-effective amendment shall be
deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering
thereof; and

        (3)  To remove from registration by means of a post-
effective amendment any of the securities being registered which
remain unsold at the termination of the offering.

        (b)  The Company hereby undertakes that, for purposes of
determining any liability under the 1933 Act, each filing of the
Company's annual report pursuant to Section 13(a) or Section
15(d) of the 1934 Act (and, where applicable, each filing of an
employee benefit plan's annual report pursuant to Section 15(d)
of the 1934 Act) that is incorporated by reference in the
registration statement shall be deemed to be a new registration
statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.

                           -5-
(c)  Insofar as indemnification for liabilities arising
under the 1933 Act may be permitted to directors, officers and
controlling persons of the Company pursuant to the foregoing
provisions, or otherwise, the Company has been advised that in
the opinion of the Commission such indemnification is against
public policy as expressed in the 1933 Act and is, therefore,
unenforceable.  In the event that a claim for indemnification
against such liabilities (other than the payment by the Company
of expenses incurred or paid by a director, officer or
controlling person of the Company in the successful defense of
any action, suit or proceeding) is asserted by such director,
officer or controlling person in connection with the securities
being registered, the Company will, unless in the opinion of its
counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question
whether such indemnification by it is against public policy as
expressed in the 1933 Act and will be governed by the final
adjudication of such issue.

                           -6-
SIGNATURES

 Pursuant to the requirements of the Securities Act of 1933,
the Company certifies that it has reasonable grounds to believe
that it meets all of the requirements for filing on Form S-8 and
has duly caused this Registration Statement to be signed on its
behalf by the undersigned, thereunto duly authorized, in the City
of Norwalk, State of Connecticut, on November 30, 1997.

                                THE PERKIN-ELMER CORPORATION

                               By:  /s/ William B. Sawch
                                    William B. Sawch
                                    Senior Vice President, General
                                    Counsel and Secretary

                       POWER OF ATTORNEY

 KNOW ALL MEN BY THESE PRESENTS, that each person whose
signature appears below hereby constitutes and appoints Dennis L.
Winger and William B. Sawch, and each of them, his true and
lawful attorney-in-fact and agent, with full power of
substitution and resubstitution, for him and in his name, place
and stead, in any and all capacities, to sign any and all
amendments (including, without limitation, post-effective
amendments) to this Registration Statement, and to file the same,
with all exhibits thereto, and other documents in connection
therewith, with the Securities and Exchange Commission, granting
unto said attorneys-in-fact and agents, and each of them, full
power and authority to do and perform each and every act and
thing requisite and necessary to be done in and about the
premises as fully to all intents and purposes as he might or
could do in person, hereby ratifying and confirming all that said
attorneys-in-fact and agents of any of them, or their or his
substitute or substitutes, may lawfully do or cause to be done by
virtue hereof.

 Pursuant to the requirements of the Securities Act of 1933,
this Registration Statement has been signed by the following
persons in the capacities and on the dates indicated.
/s/ Tony L. White                  Chairman of the Board,         November 30, 1997
     Tony L. White                  President and Chief
                                    Executive Officer
                                    (Principal Executive Officer)
-7-
/s/ Dennis L. Winger                Senior Vice President,         November 30, 1997
    Dennis L. Winger                Chief Financial Officer
                                    and Treasurer (Principal
                                    Financial Officer)

 /s/ Ugo D. DeBlasi                 Corporate Controller           November 30, 1997
     Ugo D. DeBlasi                 (Principal Accounting
                                    Officer)

/s/ Joseph F. Abely, Jr.            Director                       November 30, 1997
    Joseph F. Abely, Jr.

/s/ Richard H. Ayers                Director                       November 30, 1997
    Richard H. Ayers

                                    Director                       November   , 1997
Jean-Luc Belingard

/s/ Robert H. Hayes                 Director                       November 30, 1997
    Robert H. Hayes

/s/ Georges C. St. Laurent, Jr.     Director                       November 30, 1997
    Georges C. St. Laurent, Jr.

/s/ Carolyn W. Slayman              Director                       November 30, 1997
Carolyn W. Slayman

                                    Director                       November    , 1997
Orin R. Smith
-8-
EXHIBIT INDEX

                Exhibit No.                     Exhibit

                  5              Opinion of William B. Sawch, Esq.

                 23(1)           Consent of Price Waterhouse

                 99              Molecular Informatics, Inc. 1997 Equity
                                 Ownership Plan